Yong-Ming Zhu Selected Research

Neurocan

1/2022	Valproic Acid Inhibits Glial Scar Formation after Ischemic Stroke.
1/2020	Inhibition of GSK3β and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke via Reduction of Inflammatory Cytokine Production.
6/2019	CID1067700, a late endosome GTPase Rab7 receptor antagonist, attenuates brain atrophy, improves neurologic deficits and inhibits reactive astrogliosis in rat ischemic stroke.
1/2017	Sevoflurane postconditioning attenuates reactive astrogliosis and glial scar formation after ischemia-reperfusion brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Ming Zhu Research Topics

Disease

7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2023 - 01/2017
6	Gliosis 01/2022 - 01/2017
6	Ischemic Stroke 01/2022 - 01/2017
4	Brain Injuries (Brain Injury) 08/2023 - 01/2017
4	Infarction (Infarctions) 01/2023 - 01/2017
2	Ischemia 01/2022 - 01/2017
2	Neurologic Manifestations (Neurological Manifestations) 06/2019 - 01/2017
2	Inflammation (Inflammations) 01/2019 - 10/2018
1	Reinjuries 01/2023
1	Reperfusion Injury 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Allergic Rhinitis 08/2020
1	Immediate Hypersensitivity 08/2020
1	Cicatrix (Scar) 01/2020
1	Atrophy 06/2019
1	Brain Ischemia (Cerebral Ischemia) 10/2018

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
6	Oxygen (Dioxygen)IBA 01/2023 - 01/2017
5	Phosphotransferases (Kinase)IBA 01/2023 - 10/2018
4	necrostatin-1IBA 08/2023 - 10/2018
4	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2017
4	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2022 - 01/2017
4	NeurocanIBA 01/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2018
3	CytokinesIBA 01/2022 - 10/2018
3	Neuroprotective AgentsIBA 01/2022 - 01/2017
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 08/2023 - 01/2022
2	Cathepsin BIBA 06/2019 - 01/2017
1	Small Interfering RNA (siRNA)IBA 08/2023
1	N- (4- (N- (3- methoxypyrazin- 2- yl)sulfamoyl)phenyl)- 3- (5- nitrothiophene- 2- yl)acrylamideIBA 01/2023
1	Histones (Histone)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	CorticosteroneIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Vascular Endothelial Growth Factor DIBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2021
1	Immunoglobulin E (IgE)IBA 08/2020
1	SB 216763IBA 01/2020
1	AntibodiesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Glycogen Synthase (Synthase I)IBA 01/2020
1	Monomeric GTP-Binding ProteinsIBA 06/2019
1	CID1067700IBA 06/2019
1	GTP Phosphohydrolases (GTPases)IBA 06/2019
1	Histocompatibility Antigens Class IIIBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2018
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2017
1	CA 074 methyl esterIBA 01/2017

Therapy/Procedure

1	Intraperitoneal Injections 01/2022